Paradox Immunotherapeutics
Biotechnology, Life Science, Pharmaceutical
Founded in 2019-01-01
Toronto, Ontario, Canada
For Profit
About Paradox Immunotherapeutics
Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases. It uses an immunotherapy drug design platform to design drugs that harness the body’s own immune system to clear lethal deposits from affected organs and reverse organ damage.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: None USD
- Last Funding: None (Non-equity Assistance)
- Funding Status:
Technology Stack
Paradox Immunotherapeutics actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Life Science, Pharmaceutical
Headquarters: Toronto, Ontario, Canada